This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -4.68M -100.29M -104.13M -110.21M
Operating Gains/Losses -47.00K -1.63M 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 124.00K 457.00K 588.00K -1.03M
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 6.20M 1.27M 3.12M -995.00K
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 170.94M 697.00K -447.00K -197.00K
Other Non-Cash Items 16.37M 22.05M 5.21M 16.38M
Net Cash From Continuing Operations 184.78M -75.62M -91.08M -94.46M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 184.78M -75.62M -91.08M -94.46M
Sale of Property, Plant & Equipment 335.00K 2.17M 130.00K 85.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 212.62M 0.00
Purchases of Property, Plant & Equipment -910.00K -80.00K -1.72M -492.00K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 -111.49M 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -117.02M -108.42M 99.54M -97.81M
Issuance of Debt 0.00 84.14M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 114.00K 202.27M 1.08M 38.11M
Repayment of Long-Term Debt -1.86M -1.71M -1.57M -1.44M
Repurchase of Capital Stock -357.00K -887.00K -873.00K -285.00K
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 70.00K 0.00 -26.00K 0.00
Net Cash From Financing Activities -2.03M 283.81M -1.39M 36.38M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 65.72M 99.77M 7.08M -155.89M
LXRX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LXRX Lexicon Pharmaceuticals Inc

Chart of LXRX

Analysts Ratings for LXRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET LXRX ANALYST REPORT

LXRX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs